Kneat.com (KSI) Emerging Growth Conference 89 summary
Event summary combining transcript, slides, and related documents.
Emerging Growth Conference 89 summary
21 Jan, 2026Market context and company positioning
Global uranium demand is rising due to increased reactor builds and lower production forecasts, creating a favorable market environment for exploration companies.
The Athabasca Basin in Northern Saskatchewan is the world's highest-grade uranium jurisdiction, with grades 20 times higher than global averages.
Stallion Uranium has restructured, reprioritized exploration targets, and raised over CAD 24 million in eight months, ensuring strong financial backing.
Exploration strategy and progress
The company holds a 1,700 sq km land package in the southwestern Athabasca Basin, surrounded by major high-grade discoveries.
Recent ground EM surveys at the Coyote corridor revealed increased structural complexity and conductivity, strengthening its status as a top target.
Drilling is set to begin imminently, with at least 15 holes planned for the Coyote corridor and results expected as early as the first week of February.
Additional geophysical surveys are planned for other Tier I targets, including Stone Island, Fishhook, and Lynx.
Competitive advantages and team track record
The team has a proven record, with key members involved in three high-grade discoveries and nearly $6 billion in company sales.
The company is fully funded for aggressive exploration and aims to have multiple drill-ready Tier I targets by the end of the current program.
Improved access and infrastructure in the western Athabasca Basin now allow cost-effective exploration in previously underexplored areas.
Latest events from Kneat.com
- Software revenue up 33% in 2025; ARR at $74.1m; targeting cash flow breakeven in 2026.KSI
Q4 202526 Feb 2026 - SaaS validation platform achieves 138% net revenue retention and targets $2B+ ARR in life sciences.KSI
Small-Cap Growth Virtual Investor Conference 20243 Feb 2026 - ARR rose 60% and gross margin reached 74% in Q2 2024, with strong SaaS and partner growth.KSI
Q2 20242 Feb 2026 - Digitized validation leader achieves rapid ARR growth and major efficiency gains for life sciences.KSI
Investor presentation21 Jan 2026 - Record Q3 revenue, ARR, and margin growth, with new global contracts and strong outlook.KSI
Q3 202415 Jan 2026 - High-growth validation software leader drives digital transformation in life sciences.KSI
Planet MicroCap Showcase: VEGAS 202527 Dec 2025 - Record SaaS-driven growth, high margins, and strong cash position support 2025 momentum.KSI
Q4 202416 Dec 2025 - ARR up 51%, revenue up 37%, and profitability improved in Q1 2025.KSI
Q1 202524 Nov 2025 - Q2 revenue up 32%, ARR up 43%, with record SaaS growth and strong outlook for 2026.KSI
Q2 202523 Nov 2025